243 related articles for article (PubMed ID: 28441391)
1. Apigenin inhibits TNFα/IL-1α-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells.
Bauer D; Redmon N; Mazzio E; Soliman KF
PLoS One; 2017; 12(4):e0175558. PubMed ID: 28441391
[TBL] [Abstract][Full Text] [Related]
2. Whole Transcriptomic Analysis of Apigenin on TNFα Immuno-activated MDA-MB-231 Breast Cancer Cells.
Bauer D; Mazzio E; Soliman KFA
Cancer Genomics Proteomics; 2019; 16(6):421-431. PubMed ID: 31659097
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
4. Effect of apigenin on whole transcriptome profile of TNFα-activated MDA-MB-468 triple negative breast cancer cells.
Bauer D; Mazzio E; Hilliard A; Oriaku ET; Soliman KFA
Oncol Lett; 2020 Mar; 19(3):2123-2132. PubMed ID: 32194710
[TBL] [Abstract][Full Text] [Related]
5. Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling.
Bauer D; Redmon N; Mazzio E; Taka E; Reuben JS; Day A; Sadrud-Din S; Flores-Rozas H; Soliman KF; Darling-Reed S
Cytokine; 2015 Sep; 75(1):117-26. PubMed ID: 26100848
[TBL] [Abstract][Full Text] [Related]
6. Antitumor and Anti-Invasive Effect of Apigenin on Human Breast Carcinoma through Suppression of IL-6 Expression.
Lee HH; Jung J; Moon A; Kang H; Cho H
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31252615
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
Front Immunol; 2019; 10():757. PubMed ID: 31031757
[TBL] [Abstract][Full Text] [Related]
8. Neutralization of TNFα in tumor with a novel nanobody potentiates paclitaxel-therapy and inhibits metastasis in breast cancer.
Ji X; Peng Z; Li X; Yan Z; Yang Y; Qiao Z; Liu Y
Cancer Lett; 2017 Feb; 386():24-34. PubMed ID: 27832973
[TBL] [Abstract][Full Text] [Related]
9. Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells.
Coombs MRP; Harrison ME; Hoskin DW
Cancer Lett; 2016 Oct; 380(2):424-433. PubMed ID: 27378243
[TBL] [Abstract][Full Text] [Related]
10. Diallyl disulfide inhibits TNFα-induced CCL2 release by MDA-MB-231 cells.
Bauer D; Mazzio E; Soliman KF; Taka E; Oriaku E; Womble T; Darling-Reed S
Anticancer Res; 2014 Jun; 34(6):2763-70. PubMed ID: 24922637
[TBL] [Abstract][Full Text] [Related]
11. Sanguinarine Inhibition of TNF-α-Induced CCL2, IKBKE/NF-κB/ERK1/2 Signaling Pathway, and Cell Migration in Human Triple-Negative Breast Cancer Cells.
Messeha SS; Zarmouh NO; Antonie L; Soliman KFA
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955463
[TBL] [Abstract][Full Text] [Related]
12. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory activity of structurally related flavonoids, Apigenin, Luteolin and Fisetin.
Funakoshi-Tago M; Nakamura K; Tago K; Mashino T; Kasahara T
Int Immunopharmacol; 2011 Sep; 11(9):1150-9. PubMed ID: 21443976
[TBL] [Abstract][Full Text] [Related]
14. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
Taylor PC; Peters AM; Paleolog E; Chapman PT; Elliott MJ; McCloskey R; Feldmann M; Maini RN
Arthritis Rheum; 2000 Jan; 43(1):38-47. PubMed ID: 10643698
[TBL] [Abstract][Full Text] [Related]
15. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.
Ueno T; Toi M; Saji H; Muta M; Bando H; Kuroi K; Koike M; Inadera H; Matsushima K
Clin Cancer Res; 2000 Aug; 6(8):3282-9. PubMed ID: 10955814
[TBL] [Abstract][Full Text] [Related]
16. [Effect and mechanism of apigenin on VEGF expression in human breast cancer cells].
Jin XY; Ren CS
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):495-9. PubMed ID: 18069627
[TBL] [Abstract][Full Text] [Related]
17. Apigenin inhibits release of inflammatory mediators by blocking the NF-κB activation pathways in the HMC-1 cells.
Kang OH; Lee JH; Kwon DY
Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):473-9. PubMed ID: 21142820
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
[TBL] [Abstract][Full Text] [Related]
19. Effect of Diallyl Trisulfide on TNF-α-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells.
Kanga KJW; Mendonca P; Soliman KFA; Ferguson DT; Darling-Reed SF
Anticancer Res; 2021 Dec; 41(12):5919-5933. PubMed ID: 34848446
[TBL] [Abstract][Full Text] [Related]
20. Dietary flavonoid apigenin inhibits high glucose and tumor necrosis factor alpha-induced adhesion molecule expression in human endothelial cells.
Yamagata K; Miyashita A; Matsufuji H; Chino M
J Nutr Biochem; 2010 Feb; 21(2):116-24. PubMed ID: 19195861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
